Search results for "Mace"

showing 10 items of 4713 documents

Sleep apnea and its role in transportation safety

2017

Obstructive sleep apnea (OSA) is a main cause of excessive daytime sleepiness and increases the risk for driving accidents, which can be normalized by treatment with continuous positive airway pressure ventilation. Since it is estimated that OSA is not diagnosed in about 80% of cases, recognition of patients at risk for driving accidents is a problem from both medical and societal points of view. Strategies to screen and identify subjects at high risk for driving accidents are under study in order to improve safety on the road, especially for commercial drivers, who show a high prevalence of OSA.

medicine.medical_specialtyObstructive Sleep Apneamedicine.medical_treatmentTransportation safetyExcessive daytime sleepinessReviewSettore MED/10 - Malattie Dell'Apparato RespiratorioGeneral Biochemistry Genetics and Molecular Biologylaw.invention03 medical and health sciences0302 clinical medicinelawCPAPAnesthesiologyDriving accidentmedicineContinuous positive airway pressureGeneral Pharmacology Toxicology and PharmaceuticsOpen peer reviewGeneral Immunology and Microbiologydriving accidentsSleep apneaArticlesGeneral MedicineSleep disordersmedicine.diseaserespiratory tract diseasesObstructive sleep apnea030228 respiratory systemEmergency medicineVentilation (architecture)medicine.symptom030217 neurology & neurosurgery
researchProduct

Nutraceuticals as Lipid-Lowering Treatment in Pregnancy and Their Effects on the Metabolic Syndrome.

2015

Maternal nutrition and lifestyle before and during pregnancy influence both mother and offspring's health and can be correlated with the metabolic syndrome in later life. Findings from animal and human studies indicate that nutrition during pregnancy has an important role in microbiological, metabolic, physiologic and immunologic development and homeostasis. A low nutritional intake in early pregnancy may represent a risk for adverse effects during pregnancy as well as on birth outcome. It seems that dietary supplementation with probiotics in perinatal period may represent safe and practical approach in dealing with the most common adverse pregnancy outcomes such as obesity and gestational …

medicine.medical_specialtyOffspringPharmaceutical SciencePhysiologyOverweight03 medical and health sciences0302 clinical medicinePregnancyDiabetes mellitusInternal medicinemedicineAnimalsHumans030212 general & internal medicineObesityAdverse effectMetabolic SyndromePregnancybusiness.industryProbioticsmedicine.diseaseObesityLipidsGestational diabetesDiabetes GestationalEndocrinologyTreatment OutcomeDietary SupplementsFemaleMetabolic syndromemedicine.symptombusiness030217 neurology & neurosurgeryBiotechnologyCurrent pharmaceutical biotechnology
researchProduct

Topical therapies for oral lichen planus management and their efficacy: a narrative review.

2012

Oral Lichen Planus (OLP) is a chronic inflammatory condition implicating T cell-mediated cytotoxicity, and involving oral mucosal surfaces. Several therapeutic regimens have been evaluated to treat OLP and pain related, but often without high level of evidence. Topical formulations are the favourite for the majority of cases; bioadhesive formulations have been considered very useful and practical for local drug delivery in oral mucosa, due to the increased residence time on the oral mucosa of the dosage forms and better therapeutic efficacy. In this narrative review, authors try to illustrate the current topical managements for OLP from the accessible literature on this topic. Steroids are …

medicine.medical_specialtyOral Lichen Planus topical therapy corticosteroids aloe vera retinoids hyaluronic acid phototherapy laser therapy.Time FactorsBasiliximabHyaluronic acidAdministration TopicalEfalizumabPimecrolimusRetinoidsDrug Delivery Systemsstomatognathic systemSettore MED/28 - Malattie OdontostomatologicheDrug DiscoveryOral and maxillofacial pathologymedicineCorticosteroidsHumansAloe vera; Corticosteroids; Hyaluronic acid; Laser therapy; Oral lichen planus; Phototherapy; Retinoids; Topical therapy; Drug Discovery3003 Pharmaceutical Science; PharmacologyPharmacologybusiness.industryDrug Discovery3003 Pharmaceutical ScienceMouth MucosaPhototherapymedicine.diseaseDermatologyAloe veraAlefaceptTacrolimusInfliximabstomatognathic diseasesPhotopheresisOral lichen planusQuality of LifeTopical therapyOral lichen planusLaser Therapybusinessmedicine.drugLichen Planus Oral
researchProduct

Papierchromatographische und papierionophoretische Untersuchungen zur Freilegung und Trennung der Hypophysen-Hinterlappen-Hormone Oxytocin und Vasopr…

1956

medicine.medical_specialtyPaper chromatographyEndocrinologyOxytocinChemistryInternal medicineDrug DiscoverymedicinePharmaceutical Sciencemedicine.drugArchiv der Pharmazie
researchProduct

Ambulatory Treatment and Telemonitoring of Patients with Parkinson’s Disease

2011

Body sensor networks (BSN) promise to enhance quality of life in common human habitats. The very next and natural step towards the improvement of the already valuable applications based on BSN is the incorporation of body actuator devices which adapt its actuation dynamically based on the information provided by the body sensors, thus forming Body Sensor and actuator Networks (BS&AN). This paper shows how BS&AN can be exploited to create an innovative system to support the treatment of patients affected by Parkinson’s Disease (PD). The combination of clinical and technological knowledge in BS&AN allows to significantly improve the quality of life of patients suffering from PD.

medicine.medical_specialtyParkinson's diseasebusiness.industrymedicine.diseasePhysical medicine and rehabilitationQuality of lifeSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoAmbulatoryIntraoral deviceParkinson’s disease body sensor and actuator networks intraoral device HELP project mobile health mHealth.MedicineBody sensorsbusinessmHealthWireless sensor network
researchProduct

Molecular imaging of gastroenteropancreatic neuroendocrine tumors.

2010

Somatostatin-receptor scintigraphy has become an obligatory molecular imaging method in the management of patients with neuroendocrine tumors when metastatic disease is suspected. Using positron emission tomography and new somatostatin analogues, sensitivity of somatostatin receptor imaging has further increased. With a combination of morphologic imaging methods, such as hybrid imaging by PET/CT, this method represents the method of choice in many centers and efforts are under way to translate somatostatin receptor imaging onto a cellular level by endoscopic confocal microscopy. Other clinically relevant functional pathways in neuroendocrine tumors that are accessible by PET imaging are glu…

medicine.medical_specialtyPathologyNeuroendocrine tumorsScintigraphylaw.inventionConfocal microscopylawmedicineHumansReceptors SomatostatinGastrointestinal NeoplasmsMicroscopy Confocalmedicine.diagnostic_testbusiness.industrySomatostatin receptorGastroenterologyPet imagingmedicine.diseaseCarcinoma NeuroendocrineMolecular ImagingPancreatic NeoplasmsNeuroendocrine TumorsSomatostatinPositron emission tomographyPositron-Emission TomographyRadiologyMolecular imagingRadiopharmaceuticalsbusinessGastroenterology clinics of North America
researchProduct

Adherence issues related to sublingual immunotherapy as perceived by allergists.

2010

Silvia Scurati1, Franco Frati1, Gianni Passalacqua2, Paola Puccinelli1, Cecile Hilaire1, Cristoforo Incorvaia3, Italian Study Group on SLIT Compliance 1Scientific and Medical Department, Stallergenes, Milan, Italy; 2Allergy and Respiratory Diseases, Department of Internal Medicine, Genoa; 3Allergy/Pulmonary Rehabilitation, ICP Hospital, Milan, ItalyObjectives: Sublingual immunotherapy (SLIT) is a viable alternative to subcutaneous immunotherapy to treat allergic rhinitis and asthma, and is widely used in clinical practice in many European countries. The clinical efficacy of SLIT has been established in a number of clinical trials and meta-analyses. However, because SLIT is self-administered…

medicine.medical_specialtyPathologygenetic structuresefficacyAlternative medicineMedicine (miscellaneous)Adherence Cost Efficacy Side effects Sublingual immunotherapySettore MED/10 - Malattie Dell'Apparato Respiratoriosublingual immunotherapyALLERGENcostmedicineSubcutaneous immunotherapySublingual immunotherapyadherenceClinical efficacyIntensive care medicinePharmacology Toxicology and Pharmaceutics (miscellaneous)sublingual immunoterapyOriginal ResearchAsthmaAEROALLERGENSadherence; sublingual immunotherapy; efficacy; cost; side effectsbusiness.industryHealth Policymedicine.diseaseSliteye diseasesClinical trialside effectsPatient Preference and Adherenceadherence; sublingual immunoterapy; efficacy; cost; side effects.immunotherapysense organsAllergistsADHERENCE TO TREATMENTbusinessSocial Sciences (miscellaneous)
researchProduct

Patient perspectives in the management of asthma: improving patient outcomes through critical selection of treatment options

2010

Asthma is a chronic inflammatory disorder of the airways that requires long-term treatment, the goal of which is to control clinical symptoms for extended periods with the least possible amount of drugs. International guidelines recommend the addition of an inhaled long-acting beta2-agonist (LABA) to a low- to medium-dose inhaled corticosteroid (ICS) when low doses of ICS fail to control asthma symptoms. The fixed combined administration of ICS/LABA improves patient compliance, reducing the risk of therapy discontinuation. The relative deposition pattern of the inhaled drug to the target site is the result of a complex interaction between the device used, the aerosol formulation and the pat…

medicine.medical_specialtyPathologymedicine.drug_classMedicine (miscellaneous)ReviewSettore MED/10 - Malattie Dell'Apparato Respiratoriocompliancedevice treatment inhalers complianceMedicineinhalersIntensive care medicinePharmacology Toxicology and Pharmaceutics (miscellaneous)Asthmatherapybusiness.industryHealth PolicyTreatment optionsAsthma symptomsasthmamedicine.diseaseChronic inflammatory disorderDiscontinuationCorticosteroidBronchoconstrictionFormoterolmedicine.symptombusinessSocial Sciences (miscellaneous)medicine.drugPatient Preference and Adherence
researchProduct

Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage

2015

Background: The irradiation of head and neck cancer (HNC) often causes damage to the salivary glands. The resulting salivary gland hypofunction and xerostomia seriously reduce the patient’s quality of life. Purpose: To analyze the literature of actual management strategies for radiation-induced hypofunction and xerostomia in HNC patients. Methods: MEDLINE/PubMed and the Cochrane Library databases were electronically evaluated for articles published from January 1, 1970, to June 30, 2013. Two reviewers independently screened and included papers according to the predefined selection criteria. Results: Sixty-one articles met the inclusion criteria. The systematic review of the literature sugge…

medicine.medical_specialtyPathologymedicine.medical_treatmentMEDLINEReviewCochrane LibraryOral hygieneQuality of lifeSettore MED/28 - Malattie Odontostomatologichemedicinemanagement strategiesPharmacology (medical)General Pharmacology Toxicology and PharmaceuticsMED/42 Igiene generale e applicataIntensive care medicineMED/28 Malattie odontostomatologicheradiation-induced xerostomiaChemical Health and SafetySalivary glandbusiness.industryHead and neck cancerGeneral Medicinemedicine.diseasePathophysiologyRadiation therapymedicine.anatomical_structuresalivary gland hypofunctionradiation-induced xerostomia salivary gland hypofunction management strategiesbusinessSafety Research
researchProduct

Update in the Percutaneous Management of Coronary Chronic Total Occlusions

2018

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTOs) has been rapidly evolving during recent years. With improvement in equipment and techniques, high success rates can be achieved at experienced centers, although overall success rates remain low. Prospective, randomized-controlled data regarding optimal use and indications for CTO PCI remain limited. CTO PCI should be performed when the anticipated benefit exceeds the potential risk. New high-quality studies of the clinical outcomes and techniques of CTO PCI are needed, as is the expansion of expert centers and operators that can achieve excellent clinical outcomes in this challenging patient and lesion subgroup. In…

medicine.medical_specialtyPercutaneousbusiness.industryPotential riskmedicine.medical_treatmentTreatment outcomePercutaneous coronary intervention030204 cardiovascular system & hematologyCABG = coronary artery bypass grafting CTA = computed tomography angiography CTO = chronic total occlusion IVUS = intravascular ultrasound MACE = major adverse cardiac event(s) MT = medical therapy OMT = optimal medical therapy PCI = percutaneous coronary intervention03 medical and health sciencessurgical procedures operative0302 clinical medicineChronic diseaseCoronary occlusionConventional PCImedicinecardiovascular diseases030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessProspective cohort studyIntensive care medicine
researchProduct